Incidence and predictors of ventricular arrhythmias after ST-segment elevation myocardial infarction

American Journal of Emergency Medicine

Volumn 30, Issue 4, 2012, Pages 580-586

  Ohlow, Marc Alexander ^a   Geller, J Christoph ^a   Richter, Stefan ^a   Farah, Ahmed ^a   Müller, Stefan ^a   Fuhrmann, Jörg T ^a   Lauer, Bernward ^a  

^a ZENTRALKLINIK BAD BERKA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; SPIRONOLACTONE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD CELL COUNT; BLOOD CLOT LYSIS; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEMATOCRIT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARRHYTHMIAS, CARDIAC; CREATININE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84861145935     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2011.02.029     Document Type: Article

References (37)

1. Y. Hasin, N. Danchin, and G. Filippatos Recommendations for structure, organization, and operation of intensive cardiac care units Eur Heart J 26 2005 1676 1682
2. B. Drew, R. Califf, and M. Funk Practice standards for electrocardiographic monitoring in hospital settings Circulation 110 2004 2721 2746
3. F. De Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation Eur Heart J 29 2008 2909 2945
4. M. Dalby, A. Bouzamondo, and P. Lechat Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis Circulation 108 2003 1809 1814
5. E. Keely, J. Boura, and C. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials Lancet 361 2003 13 20
6. J.S. Alpert, K. Thygesen, and E. Antman Myocardial infarction redefined - a consensus document of the European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513
7. A. Maggioni, G. Zuanetti, and M. Franzosi Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolysis era: GISSI-2 results Circulation 87 1993 312 322
8. Z. Babic, V. Nikolic, and N. Bulj Role of (reperfusion) arrhythmias in predicting outcome in patients with ST-elevation acute myocardial infarction Neurol Croat 55 2006 63 73
9. G. Jensen, C. Torp-Pedersen, and P. Hildebrandt Does in-hospital ventricular fibrillation affect prognosis after myocardial infarction? Eur Heart J 18 1997 919 924
10. K. Rahimi, S. Watzlavek, and H. Thiele Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-elevation myocardial infarction in patients with early invasive treatment Eur Heart J 27 2006 1706 1711
11. M. Chung, D. Martin, and D. Sprecher C-reactive protein elevation in patients with atrial fibrillation: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
12. M. Engelmann, and J. Svendsen Inflammation in the genesis and perpetuation of atrial fibrillation Eur Heart J 26 2005 2083 2092
13. M. Burr, R. Holliday, and A. Fehily Hematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial Eur Heart J 13 1992 166 170
14. A. Burke, R. Tracy, and F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies Circulation 105 2002 2019 2023
15. G. Greenberg, A. Assali, and H. Vaknin-Assa Hematocrit levels as a marker of outcome in ST-segment elevation myocardial infarction Am J Cardiol 105 2010 435 440
16. M. Sabatine, D. Morrow, and R. Giugliano Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
17. J. Fuchs, I. Weinberger, and A. Terboul Plasma viscosity and hematocrit in the course of acute myocardial infarct Eur Heart J 8 11 1987 1195 1200
18. C. Granger, R. Goldberg, and O. Dabbous Predictors of hospital mortality in the global registry of acute coronary events Arch Inn Med 163 2003 2345 2353
19. J. Al Suwaidi, D. Reddan, and K. Williams Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980
20. R. Mehta, A. Starr, and R. Lopes Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 17 2009 1779 1789
21. A. Cheema, K. Sheu, and M. Parker Nonsustained ventricular tachycardia in the setting of acute myocardial infarction Circulation 1998 2030 2036
22. T. Nguyen, E. Salibi, and J.P. Rouleau Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: effect of ramipril and hydralazine Circulation 98 1998 2074 2080
23. G. Montalescot, G. Cayla, and J. Collet Immediate vs. delayed intervention or acute coronary syndrome JAMA 302 9 2009 947 954
24. G. Montalescot, P. Barragan, and O. Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 25 2001 1895 1903
25. S. Rezkalla, and S. Kloner No-reflow phenomenon Circulation 105 5 2002 656 663
26. T. Svilaas, P. Vlaar, and I. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 6 2008 557 567
27. G. De Luca, H. Suryapranata, and F. Zijlstra Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 42 2003 991 997
28. C. Cannon, C. Gibson, and C. Lambrew Relationship of symptom-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction J Am Med Ass 283 2000 2941 2947
29. M. Domanski, D. Exner, and C. Borkowf Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction: a meta analysis of randomized clinical trials J Am Coll Cardiol 33 1999 598 604
30. Z.M. Chen, L.X. Jiang, and Y.P. Chen Early intravenous than oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial Lancet 366 2005 1622 1632
31. E.D. Peterson, C. Pollack, M. Roe, L. Parsons, K. Littrell, J. Canto, and H. Barron Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction J Am Coll Cardiol 42 2003 45 53
32. T.B. Genetta, and V.F. Mauro Abciximab: a new antiaggregant used in angioplasty Ann Pharmacother 30 1996 251 257
33. J. Kang, and A. Leaf Antiarrhythmic effects of polyunsaturated fatty acids: recent studies Circulation 94 1996 1774 1780
34. W. Lands Biochemistry and physiology of eiconasoid precursors in cell membranes Eur Heart J 22 2001 D22 25
35. R. Marchioli, E. Bomba, and D. DiGregorio Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction Circulation 105 2002 1897 1903
36. A. Leaf The electrophysiologic basis for the antiarrhythmic actions of polyunsaturated fatty acids Eur Heart J 22 2001 D98 105
37. J. MacDonald, and A. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161